

47. Gastroenterology. 2015 Jan;148(1):215-9; quiz e16-7. doi:
10.1053/j.gastro.2014.10.039. Epub 2014 Oct 31.

American Gastroenterological Association Institute guideline on the prevention
and treatment of hepatitis B virus reactivation during immunosuppressive drug
therapy.

Reddy KR(1), Beavers KL(2), Hammond SP(3), Lim JK(4), Falck-Ytter YT(5); American
Gastroenterological Association Institute.

Collaborators: Flamm SL, Gerson LB, Hirano I, Nguyen GC, Rubenstein JH, Singh S, 
Smalley WE, Stollman N, Sultan S, Vege SS, Wani SB, Weinberg DS, Yang YX.

Author information: 
(1)Division of Gastroenterology and Hepatology, University of Pennsylvania,
Philadelphia, Pennsylvania.
(2)Division of Gastroenterology and Hepatology, Medical University of South
Carolina, Charleston, South Carolina.
(3)Division of Infectious Diseases, Brigham & Women's Hospital, Dana-Farber
Cancer Institute and Harvard Medical School, Boston, Massachusetts.
(4)Division of Gastroenterology and Hepatology, Yale University School of
Medicine, New Haven, Connecticut.
(5)Division of Gastroenterology and Hepatology, Department of Medicine, Case and 
VA Medical Center, Case Western Reserve University, Cleveland, Ohio.

Erratum in
    Gastroenterology. 2015 Feb;148(2):455. multiple investigator names added.

DOI: 10.1053/j.gastro.2014.10.039 
PMID: 25447850  [Indexed for MEDLINE]
